ResearcherUniversity of Tennessee Health Science CenterActive in the last 2 years

Rui Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9348-1058; OpenAlex author ID A5084160443. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancer. Co-author DOI 10.1111/bph.70294 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wěi Li · 1 shared paper, 2026 · strength 0.29
- Paper Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour … DOI 10.1111/bph.70294 ↗
Chun Cai · 1 shared paper, 2026 · strength 0.29
- Paper Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour … DOI 10.1111/bph.70294 ↗
Evan Scott Glazer · 1 shared paper, 2026 · strength 0.29
- Paper Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour … DOI 10.1111/bph.70294 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.